Loading...
Docoh

Aurinia Pharmaceuticals (AUPH)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
ESG term mentions
In last year of SEC filings
AtmosphereCarbon FootprintCircularClimateClimate ChangeCO2EmissionEnvironmentEnvironmentalEnvironmental ProtectionFlaringGreenhouse Gas EmissionMaterialsNatureOffsetPackagePackagingPandemicPlanetRaw MaterialsRegenerativeRenewableScarcityWasteWaterWindAccessAccess and affordabilityAffordabilityAsianBenefitsBlackCharitableCharityCollective BargainingCommunityCultureCustomerCyberCybersecurityData PrivacyData SecurityDeathDemographicsDisabilityDiversityEmployeeEmployee RetentionEngagementEthnicityGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHireHiringHispanicHuman CapitalHuman ResourcesIncidentInjuriesInjuryLGBTQMinorityPay for PerformancePerquisitesPrivacyProduct QualityProduct SafetyRecallRecruitRecruitmentReimbursementRetentionRetirementSafetySkillSkilledSkillsSocialSocietyStakeholderSupplierSupply ChainTalentTrainingUnionVolunteerWomenWorking ConditionAnti-corruptionAssessmentAssuranceAttorney GeneralAttorneys GeneralAuditBoard RefreshmentBonusBriberyChronicClass Action LawsuitClassifiedClawbackCommitmentConflict of InterestControversyCorporate GovernanceDepartment ofESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIndependenceIndependentIndependent ChairInnovationInnovativeInvestigationLawsuitLeadershipLitigationLong-termMajorityMissionOverseeOversightPerquisitePlaintiffPoison PillProcurementProxy AccessPurposeQuality StandardR&DRecoupReputationReputationalResearch and DevelopmentResilientResponsibilityResponsibleShareholder ProposalsSpecial MeetingStewardshipStrategySustainabilityTargetsTaxTax Gross UpTenureTerm LimitTransparencyVoting Rights
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


(a)The Company held the 2022 Meeting virtually on May 17, 2022.


(b)The following proposals were voted upon at the 2022 Meeting and the final voting results with respect to each such proposal are set forth below:


Proposal 1: Based upon the following votes, the shareholders elected Dr. George Milne, Mr. Peter Greenleaf, Dr. David R.W. Jayne, Mr. Joseph P. Hagan, Dr. Daniel Billen, Mr. R. Hector MacKay-Dunn, Ms. Jill Leversage, Mr. Timothy P. Walbert and Dr. Brinda Balakrishnan to serve as members of the Company's board of directors until the annual general meeting of shareholders to be held in 2023.


NomineeForWithheldBroker Non-Votes
Dr. George Milne26,713,17617,437,78127,895,212
Mr. Peter Greenleaf31,700,20012,450,75727,895,212
Dr. David R.W. Jayne33,300,96210,859,99527,895,212
Mr. Joseph P. Hagan24,070,89720,080,06027,895,212
Dr. Daniel Billen33,482,51810,668,43927,895,212
Mr. R. Hector MacKay-Dunn26,206,91317,944,04427,895,212
Ms. Jill Leversage27,594,23516,556,72227,895,212
Mr. Timothy P. Walbert33,368,94610,782,01127,895,212
Dr. Brinda Balakrishnan34,251,0649,899,89327,895,212



Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2023 or until a successor is appointed.


ForAgainstAbstain
63,341,9906,693,2402,000,938



Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.


ForAgainstAbstainBroker Non-Votes
33,050,50110,490,227610,23127,895,210